Does GE HEALTHCARE TECHNOLOGIES INC. have an economic moat?

Based on its FY2025 SEC filings, the Moat Index scores GE HEALTHCARE TECHNOLOGIES INC. (GEHC) 52.9 out of 100 — a Shallow moat. The four filters behind that score (each 0–100): pricing power 70, returns on capital 70, balance-sheet safety 36, capital discipline 19.

How has GEHC's Moat Score changed over time?

The record logs 1 reading since Jul 18, 2026; the latest reads 52.9 out of 100 (shallow moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.

The Moat Index

GE HEALTHCARE TECHNOLOGIES INC.

GEHC · Healthcare · FY2025 filings · Shallow moat ·

Doesn't clear the bar

Shallow moat

The four filters

Pricing power70

Median gross margin 40.5% over 5y, very stable.

Returns on capital70

Median ROIC 13.0%, above the 9% hurdle in 100% of years.

Balance-sheet safety36

Net debt/EBITDA 2.2x, interest coverage 6x.

Capital discipline19

Owner earnings -5.4%/yr, share count flat.

Margin of safety

Above valueOn sale

No price data

Owner earnings (normalized): $1.6B
Est. intrinsic value / share: —
Recent price: $63.07
Discount to value: No price data

Conservative model: 9% discount rate, 0% assumed growth (capped at 4%), maintenance capex ≈ min(capex, D&A).

6 years of fundamentals

The business, in plain English

GE HEALTHCARE TECHNOLOGIES INC. booked $20.6B of revenue in FY2025 in the Healthcare sector and kept 40.0% of it as gross profit — a solid-margin business by that measure. After every other cost, 10.1% of each revenue dollar reached the bottom line.

It earned 13.1% on invested capital in FY2025, with a median of 13.0% across 5 filed years. The Returns on Capital filter above scores it 70/100.

The balance sheet carried $10.5B of total debt in FY2025 against $1.6B of owner earnings — roughly 6.6 years of owner earnings to retire it all. Balance-Sheet Safety scores it 36/100.

Put together: Returns on Capital is the strongest of the four filters (70/100) and Capital Discipline the weakest (19/100), which is how GEHC lands at 53/100 — a Shallow moat.

This breakdown is generated from the filed numbers and sub-scores above — no outside narrative, no estimates. Where a filing doesn’t disclose an input, the sentence that would need it is omitted instead of guessed.

RevenueSales, as filed$20.6B FY2025

Gross marginRevenue kept after cost of goods40.0% FY2025

Return on invested capitalOperating profit on the capital employed13.1% FY2025

Owner earningsCash an owner could take out$1.6B FY2025

Gaps in a line mean that item isn’t in GEHC’s filings for that year — the series is never interpolated or estimated. The Table view lists every filed value, including operating and net margins, total debt, and share count.

Moat Score history

Moat Score over timeLast scored reading of each day, on the 0–100 scale52.9 / 100

Score history begins Jul 18, 2026 — the record builds from here and can’t be backfilled.

Tier changesSame-methodology crossings of the Wide / Narrow / Shallow bars

None yet — GEHC has read Shallow moat for every logged capture since Jul 18, 2026.

Scores are logged append-only and never overwritten — this record can’t be backfilled, which is exactly why it’s worth keeping.

Track record

How GE HEALTHCARE TECHNOLOGIES INC.’s moat rated in each of the years we can reconstruct from its filings — scored only on what was knowable at the time — and what its price and returns did afterward. The score never saw a price; the two are joined only in hindsight, for education, not as a signal.

As-of Moat Score (dot colored by tier)Indexed price (total-return (dividends reinvested))Rated Wide-moat that year

How to read this: each dot is what the engine would have scored GEHC on that December 31; the line below is its total-return price path (dividends reinvested) in the years since.

Two tracks, one timeline: the score has its own 0–100 scale (top), the price its own 100-based scale (bottom) — never a shared axis. The price path is a total-return (dividends reinvested) index built from the same data the forward returns use; gaps in the score line are years with no reconstructed rating (see the table for why). The Table view carries every value.

What followed, in the years it rated Wide

In the reconstructed history shown, GEHC did not rate Wide-moat in any year, so there is no wide-moat track record to report. That absence is itself the honest answer — we don’t manufacture a comparison where the rating never earned one.

Healthcare context

#111 of 461 scored Healthcare companies, ranked by Moat Score.

Nearest peers by Moat Score

#109VCYT VERACYTE, INC.53.6 out of 100, Shallow moatShallow moat
#110ALKS Alkermes plc.53.0 out of 100, Shallow moatShallow moat
#112ANIK Anika Therapeutics, Inc.52.6 out of 100, Shallow moatShallow moat
#113MRVI Maravai LifeSciences Holdings, Inc.52.2 out of 100, Shallow moatShallow moat

Compare GEHC with its nearest peers →All Healthcare companies on the Index →

Common questions about GEHC

Does GE HEALTHCARE TECHNOLOGIES INC. have an economic moat?: Based on its FY2025 SEC filings, the Moat Index scores GE HEALTHCARE TECHNOLOGIES INC. (GEHC) 52.9 out of 100 — a Shallow moat. The four filters behind that score (each 0–100): pricing power 70, returns on capital 70, balance-sheet safety 36, capital discipline 19.
How has GEHC's Moat Score changed over time?: The record logs 1 reading since Jul 18, 2026; the latest reads 52.9 out of 100 (shallow moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.

Embed this score on your site

One iframe, no script. The badge shows GEHC’s live Moat Score, updates itself as new filings are scored, and links back here. How it works.

<iframe
  src="https://buylikebuffett.com/embed/GEHC"
  width="340" height="150" style="border:0"
  title="GEHC Moat Score — The Moat Index"
  loading="lazy"></iframe>

Scored from primary SEC filings via the public methodology. Educational only — not a recommendation to buy or sell GEHC. See the disclaimer.